A public health approach for deciding policy on infant feeding and mother-infant contact in the context of COVID-19.


Journal

The Lancet. Global health
ISSN: 2214-109X
Titre abrégé: Lancet Glob Health
Pays: England
ID NLM: 101613665

Informations de publication

Date de publication:
04 2021
Historique:
received: 16 09 2020
revised: 16 11 2020
accepted: 10 12 2020
pubmed: 26 2 2021
medline: 26 3 2021
entrez: 25 2 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has raised concern about the possibility and effects of mother-infant transmission of SARS-CoV-2 through breastfeeding and close contact. The insufficient available evidence has resulted in differing recommendations by health professional associations and national health authorities. We present an approach for deciding public health policy on infant feeding and mother-infant contact in the context of COVID-19, or for future emerging viruses, that balances the risks that are associated with viral infection against child survival, lifelong health, and development, and also maternal health. Using the Lives Saved Tool, we used available data to show how different public health approaches might affect infant mortality. Based on existing evidence, including population and survival estimates, the number of infant deaths in low-income and middle-income countries due to COVID-19 (2020-21) might range between 1800 and 2800. By contrast, if mothers with confirmed SARS-CoV-2 infection are recommended to separate from their newborn babies and avoid or stop breastfeeding, additional deaths among infants would range between 188 000 and 273 000.

Identifiants

pubmed: 33631131
pii: S2214-109X(20)30538-6
doi: 10.1016/S2214-109X(20)30538-6
pmc: PMC7906661
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e552-e557

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Medical Research Council
ID : MR/L004283/1
Pays : United Kingdom

Informations de copyright

Copyright © 2021 This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.

Auteurs

Nigel Rollins (N)

Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland. Electronic address: rollinsn@who.int.

Nicole Minckas (N)

Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland.

Fyezah Jehan (F)

Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.

Rakesh Lodha (R)

Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.

Daniel Raiten (D)

Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.

Claire Thorne (C)

UCL Great Ormond Street Institute of Child Health, University College London, London, UK.

Philippe Van de Perre (P)

Pathogenesis and Control of Chronic Infections, INSERM, Etablissement Français du Sang, University of Montpellier, CHU Montpellier, Montpellier, France.

Mija Ververs (M)

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Neff Walker (N)

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Rajiv Bahl (R)

Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland.

Cesar G Victora (CG)

International Center for Equity in Health, Federal University of Pelotas, Pelotas, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH